RE: Concerns setting in10 Dec 2022 11:13
If it helps Thompi, most of us Scancell have been 60% plus down over the same period. Now 125% up over last weeks. I think Angle is my lowest risk investment but we will have to wait and see as with all investments. If you look at the fact that Angle can prove beyond doubt that it not only has value but out performs its peers with the whole liquid biopsy space, it only makes it more frustrating that the commercial progress is slow.